IDEXX Labs (IDXX) Reports Q3 EPS of $0.52, Beats by 7c; Guides FY09, FY10
IDXX Hot Sheet
EPS Growth %: +16.1%Financial Fact:
Cost of product revenue: 75.21M
Today's EPS Names:
TNP, MENT, More
IDEXX Laboratories Inc. (Nasdaq: IDXX) reports Q3 EPS of $0.52, 7 cents better than the analyst estimate of $0.45. Revenue for the quarter was $259.1 million, which compares to the estimate of $253.17 million.
Sees FY09 EPS of $1.92-$1.95 on sales of $1.02 billion. The Street is currently looking for FY09 EPS of $1.90 and sales of $1.02 billion.
For FY10, IDEXX sees EPS of $2.15-$2.25 on sales of $1.08-$1.1 billion. The Street is looking for FY10 EPS and sales of $2.17 and $1.11 billion, respectively.
Sees FY09 EPS of $1.92-$1.95 on sales of $1.02 billion. The Street is currently looking for FY09 EPS of $1.90 and sales of $1.02 billion.
For FY10, IDEXX sees EPS of $2.15-$2.25 on sales of $1.08-$1.1 billion. The Street is looking for FY10 EPS and sales of $2.17 and $1.11 billion, respectively.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Jiayuan.com (DATE) Reports In-Line Q1 EPS of 5c; Guides Q2 Revs
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
